PSKI and its modulators for the treatment/diagnosis of cancer

Details for Australian Patent Application No. 2006248789 (hide)

Owner UCB Pharma S.A.

Inventors Stamps, Alasdair Craig

Agent Watermark

Pub. Number AU-A-2006248789

PCT Pub. Number WO2006/123122

Priority 0510089.6 17.05.05 GB

Filing date 16 May 2006

Wipo publication date 23 November 2006

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/123122 Priority application(s): WO2006/123122

15 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006248799-Sanitary product

2006248788-Histone deacetylase inhibitors